Pharmacy Market BUZZ

Market News, Products, Services, and Trends

(#11 of 12): What is the current state of the federal investigation landscape? | Brian E. Dickerson | FisherBroyles



#11: What is the current state of the federal investigation landscape? | Brian E. Dickerson | FisherBroyles 



Watch the Full Series


#1: What are the implications of “fraud, waste, and abuse” prosecution and false claims? | Brian E. Dickerson | FisherBroyles 

 


#2: What to expect regarding the PBMs’ ongoing war against independent pharmacies? | Anthony J. Calamunci | FisherBroyles 

 


#3: What is the importance of seeking legal counsel when dealing with issues of compliance? | Brian E. Dickerson | FisherBroyles 

 


#4: What are best practices when dealing with marketers? | Anthony J. Calamunci | FisherBroyles 

 


#5: What precautions should pharmacies practice when affiliating with outside entities? | Anthony J. Calamunci | FisherBroyles 

 


#6: What is the future of compounding in the wake of Tricare Reform? | Brian E. Dickerson | FisherBroyles 

 


#7: What are best practices for audit response? | Anthony J. Calamunci | FisherBroyles 

 


#8: What are the implications of receiving a Civil Investigative Demand (CID)? | Brian E. Dickerson | FisherBroyles 

 


#9: What are best practices when modifying PBM Agreements? | Anthony J. Calamunci | FisherBroyles 

 


#10: What is the relationship between the patient and the prescriber? | Anthony J. Calamunci | FisherBroyles 

 


#11: What is the current state of the federal investigation landscape? | Brian E. Dickerson | FisherBroyles 

 


#12: What are the risks and consequences of non-compliant data breaches? | Brian E. Dickerson | FisherBroyles 



Today's Posts
Subscribe

This post is related to:

Certification & Accreditation Consulting & Compliance (Retail/Independent)